News Archives - VIPOC

News vitiligo treatment

21 October 2024

Incyte Announces Health Canada Approval of OPZELURA® (ruxolitinib) Cream for the Treatment of Atopic Dermatitis (AD) and Nonsegmental Vitiligo

News provided by Incyte Biosciences Canada - First and only…

Marketing 0

Love0

Opzelura Drug in France

News Non classé

4 October 2024

Opzelura the first drug against vitiligo available in pharmacies

The wait was great! The Official Journal of July 23, 2024 has…

Marketing 0

Love0

Member Events News

9 July 2024

The Mexican Vitiligo and Skin Disease: Vitiligo A Skin of Colors

The Mexican Vitiligo and Skin Disease organisation inaugurated the travelling…

Marketing 0

Love0

Member Events News

5 July 2024

World Vitiligo Day 2024 Highlights

We are thrilled to announce that World Vitiligo Day was…

Marketing 0

Love0

News

3 July 2024

Vitiligo recognised as a disease in D.R. Congo

The Provincial Minister of Health of Haut-Katanga (Democratic Republic of…

Marketing 0

Love0

News

2 May 2024

Beautifully Unblemished April Newsletter 2024

Beautifully Unblemished April Newsletter is here, and it's all about…

Marketing 0

Love0

News vitiligo treatment

27 March 2024

Tacrolimus 0.1% approved for vitiligo treatment

The French National Agency for the Safety of Medicines has…

Marketing 0

Love0

News

24 March 2024

New Expert Recommendations on Pediatric Vitiligo Care

By the way, have you seen this? The first-ever US…

Marketing 0

Love0

© 2025 VIPOC. Copyright © VIPOC Built by Simboti Digital All rights reserved.|Privacy Policy - English|Privacy Policy - French